2667 related articles for article (PubMed ID: 18631163)
21. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of additional blood screening tests in the Netherlands.
Borkent-Raven BA; Janssen MP; van der Poel CL; Bonsel GJ; van Hout BA
Transfusion; 2012 Mar; 52(3):478-88. PubMed ID: 21880046
[TBL] [Abstract][Full Text] [Related]
23. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
Stramer SL; Zou S; Notari EP; Foster GA; Krysztof DE; Musavi F; Dodd RY
Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101
[TBL] [Abstract][Full Text] [Related]
24. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program.
Satake M; Taira R; Yugi H; Hino S; Kanemitsu K; Ikeda H; Tadokoro K
Transfusion; 2007 Jul; 47(7):1197-205. PubMed ID: 17581154
[TBL] [Abstract][Full Text] [Related]
25. Detection of HCV and HIV-1 antibody negative infections in Scottish and Northern Ireland blood donations by nucleic acid amplification testing.
Jarvis LM; Dow BC; Cleland A; Davidson F; Lycett C; Morris K; Webb B; Jordan A; Petrik J
Vox Sang; 2005 Oct; 89(3):128-34. PubMed ID: 16146504
[TBL] [Abstract][Full Text] [Related]
26. Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors.
Japanese Red Cross NAT Screening Research Group
Jpn J Infect Dis; 2000 Jun; 53(3):116-23. PubMed ID: 10957709
[TBL] [Abstract][Full Text] [Related]
27. HBV NAT positive [corrected] blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA.
Yoshikawa A; Gotanda Y; Itabashi M; Minegishi K; Kanemitsu K; Nishioka K;
Vox Sang; 2005 Feb; 88(2):77-86. PubMed ID: 15720604
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA.
McCormick MK; Dockter J; Linnen JM; Kolk D; Wu Y; Giachetti C
J Clin Virol; 2006 Jul; 36(3):166-76. PubMed ID: 16427802
[TBL] [Abstract][Full Text] [Related]
29. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
[TBL] [Abstract][Full Text] [Related]
30. Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panels.
Assal A; Barlet V; Deschaseaux M; Dupont I; Gallian P; Guitton C; Morel P; van Drimmelen H; David B; Lelie N; De Micco P
Transfusion; 2009 Feb; 49(2):301-10. PubMed ID: 19389212
[TBL] [Abstract][Full Text] [Related]
31. Italian blood donors with anti-HBc and occult hepatitis B virus infection.
Manzini P; Girotto M; Borsotti R; Giachino O; Guaschino R; Lanteri M; Testa D; Ghiazza P; Vacchini M; Danielle F; Pizzi A; Valpreda C; Castagno F; Curti F; Magistroni P; Abate ML; Smedile A; Rizzetto M
Haematologica; 2007 Dec; 92(12):1664-70. PubMed ID: 18055990
[TBL] [Abstract][Full Text] [Related]
32. Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors.
Makroo RN; Choudhury N; Jagannathan L; Parihar-Malhotra M; Raina V; Chaudhary RK; Marwaha N; Bhatia NK; Ganguly AK
Indian J Med Res; 2008 Feb; 127(2):140-7. PubMed ID: 18403791
[TBL] [Abstract][Full Text] [Related]
33. Comparative analysis of triplex nucleic acid test assays in United States blood donors.
Stramer SL; Krysztof DE; Brodsky JP; Fickett TA; Reynolds B; Dodd RY; Kleinman SH
Transfusion; 2013 Oct; 53(10 Pt 2):2525-37. PubMed ID: 23550838
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of viral markers among first-time Arab blood donors in Kuwait.
Ameen R; Sanad N; Al-Shemmari S; Siddique I; Chowdhury RI; Al-Hamdan S; Al-Bashir A
Transfusion; 2005 Dec; 45(12):1973-80. PubMed ID: 16371052
[TBL] [Abstract][Full Text] [Related]
35. Identification of low HBV-DNA levels by nucleic acid amplification test (NAT) in blood donors.
Dettori S; Candido A; Kondili LA; Chionne P; Taffon S; Genovese D; Iudicone P; Miceli M; Rapicetta M
J Infect; 2009 Aug; 59(2):128-33. PubMed ID: 19586663
[TBL] [Abstract][Full Text] [Related]
36. Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing.
Offergeld R; Faensen D; Ritter S; Hamouda O
Euro Surveill; 2005 Feb; 10(2):8-11. PubMed ID: 15735310
[TBL] [Abstract][Full Text] [Related]
37. Occult hepatitis B virus infection: implications in transfusion.
Allain JP
Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
[TBL] [Abstract][Full Text] [Related]
38. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing.
Zou S; Dorsey KA; Notari EP; Foster GA; Krysztof DE; Musavi F; Dodd RY; Stramer SL
Transfusion; 2010 Jul; 50(7):1495-504. PubMed ID: 20345570
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience.
O'Brien SF; Fearon MA; Yi QL; Fan W; Scalia V; Muntz IR; Vamvakas EC
Transfusion; 2007 Oct; 47(10):1809-15. PubMed ID: 17880605
[TBL] [Abstract][Full Text] [Related]
40. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B
Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
